In a rare le­gal de­feat, Bris­tol My­ers Squibb and Sanofi fined $834M for 'de­cep­tive mar­ket­ing' on best-sell­ing blood thin­ner Plav­ix

By the time the FDA slapped a black box warn­ing on Plav­ix in 2010, the block­buster blood thin­ner had been on the mar­ket for 13 years and reaped bil­lions of dol­lars — enough to give it a sol­id spot among the best-sell­ing drugs of all time even to this day, de­spite reach­ing peak sales in 2011.

On Mon­day, a judge in Hawaii sided with the state in or­der­ing its mak­ers, Bris­tol My­ers Squibb and Sanofi, to hand back $834 mil­lion of that.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER